$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Pre-Market Stock Futures: The futures are trading lower on Tuesday, but another week and another set of new highs for the S&P 500 and the Nasdaq, as AI fever overshadowed Iran's peace counteroffer dis
Why Insulet (PODD) is a Top Value Stock for the Long-Term
10:40am, Monday, 11'th May 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Insulet Corporation (PODD) Q1 2026 Earnings Call Transcript
12:51pm, Wednesday, 06'th May 2026
Insulet Corporation (PODD) Q1 2026 Earnings Call Transcript
Insulet (PODD) Loses 17.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
10:35am, Wednesday, 06'th May 2026
Insulet (PODD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising e
Insulet (PODD) Q1 Earnings and Revenues Top Estimates
09:25am, Wednesday, 06'th May 2026
Insulet (PODD) came out with quarterly earnings of $1.42 per share, beating the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $1.02 per share a year ago.
Insulet lifts annual revenue forecast after quarterly beat on strong insulin pump demand
07:46am, Wednesday, 06'th May 2026
Insulet raised its annual revenue growth forecast on Wednesday after reporting better-than-expected quarterly results, driven by strong demand for its tubeless insulin pumps that eliminate the n
Insulet Reports First Quarter 2026 Results
07:00am, Wednesday, 06'th May 2026
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities
07:00am, Tuesday, 05'th May 2026
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
Insulet (PODD) is an Incredible Growth Stock: 3 Reasons Why
01:45pm, Monday, 04'th May 2026
Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.
Insulet (PODD) Upgraded to Buy: Here's Why
01:01pm, Monday, 04'th May 2026
Insulet (PODD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes
07:00am, Monday, 04'th May 2026
ACTON, Mass.--(BUSINESS WIRE)--Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes.
Insulet Corp (PODD) Shares Surge 7.6% -- What GF Score of 85 Tells Investors
06:20pm, Thursday, 30'th Apr 2026
On April 30, 2026, Insulet Corp (PODD) shares rose 7.6% today, bringing the current price to $172.14. However, the stock has faced significant volatility, with
PAHC vs. PODD: Which Stock Is the Better Value Option?
12:40pm, Thursday, 30'th Apr 2026
Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or Insulet (PODD). But which of these two stocks presents investors with the bet
FDA Flags High-Risk Recall Of Insulet's Omnipod 5 Pods Over Insulin Delivery Concerns
02:30pm, Wednesday, 29'th Apr 2026
The U.S. Food and Drug Administration (FDA) has classified a recall of Insulet Corporation's (NASDAQ:PODD) Omnipod 5 Pods as its most serious type, warning that continued use of affected devices could
Insulet to Participate in BofA Securities 2026 Health Care Conference
07:00am, Tuesday, 28'th Apr 2026
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will pres
Sign In
Buy PODD